Cardiovascular Health Improvement Project
CHIP
1 other identifier
observational
15,000
1 country
1
Brief Summary
The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Aug 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2013
CompletedFirst Submitted
Initial submission to the registry
December 1, 2014
CompletedFirst Posted
Study publicly available on registry
December 3, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2053
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 1, 2053
April 29, 2026
April 1, 2026
40 years
December 1, 2014
April 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Establishing a biobank of patients with Aortic Disease
Establish a biobank of blood, serum, plasma, tissue, and clinical data of patients with any form of aortic disease
40 years
Study Arms (2)
Aortic Disease
Patients with a diagnosis of any form of Aortic Disease
Controls
Patients without a diagnosis of Aortic Disease
Eligibility Criteria
Outpatient clinic
You may qualify if:
- Any patient over the age of 18 who is able/willing to give informed consent
- Patients \<18 years of age with parental consent and assent (if assent is applicable for their age)
- Diagnosis of:
- aortic pathology potentially due to a known or suspected inherited condition
- Idiopathic aortic aneurysm
- Interesting of novel vascular pathology in the aorta or main branches
- Family history of aortic or vascular disease
- Other cardiovascular disease
- Healthy controls with no apparent cardiovascular disease
You may not qualify if:
- \- Not willing or able to sign the consent
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
Related Publications (1)
Love-Nichols J, Uhlmann WR, Arscott P, Willer C, Hornsby W, Roberts JS. A survey of aortic disease biorepository participants' preferences for return of research genetic results. J Genet Couns. 2021 Jun;30(3):645-655. doi: 10.1002/jgc4.1341. Epub 2020 Dec 14.
PMID: 33319384DERIVED
Biospecimen
Blood, Tissue
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marion A Hofmann Bowman, PhD, MD
University of Michigan
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Target Duration
- 40 Years
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Internal Medicine
Study Record Dates
First Submitted
December 1, 2014
First Posted
December 3, 2014
Study Start
August 1, 2013
Primary Completion (Estimated)
August 1, 2053
Study Completion (Estimated)
August 1, 2053
Last Updated
April 29, 2026
Record last verified: 2026-04